Schofield, Behnaz, Gregory, Clive ORCID: https://orcid.org/0000-0003-4876-3982, Gal, Micaela ORCID: https://orcid.org/0000-0002-1326-190X, Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Naik, Gurudutt ORCID: https://orcid.org/0000-0002-7946-2042, Hay, Alastair and Francis, Nick ORCID: https://orcid.org/0000-0001-8939-7312 2020. The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study. BJGP Open 4 (2) , 20X101006. 10.3399/bjgpopen20X101006 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutrophilic inflammation, and may be a useful marker of bacterial throat infections. Aim To assess the feasibility of measuring calprotectin from throat swabs, and assess whether individuals with sore throats likely to be caused by streptococcal infections have apparently higher throat calprotectin levels than other individuals with sore throat and healthy volunteers. Design & setting A proof of concept case–control study was undertaken, which compared primary care patients with sore throats and healthy volunteers. Method Baseline characteristics and throat swabs were collected from 30 primary care patients with suspected streptococcal sore throat, and throat swabs were taken from 10 volunteers without sore throat. Calprotectin level determination and rapid antigen streptococcal testing were conducted on the throat swab eluents. Calprotectin levels in the following groups were compared: volunteers without a sore throat; all patients with a sore throat; patients with a sore throat testing either negative or positive for streptococcal antigen; and those with lower and higher scores on clinical prediction rules for streptococcal sore throat. Results Calprotectin was detected in all throat swab samples. Mean calprotectin levels were numerically higher in patients with sore throat compared with healthy volunteers, and sore throat patients who had group A streptococci antigen detected compared with those who did not. Conclusion Calprotectin can be measured from throat swab samples and levels are consistent with the hypothesis that streptococcal infection leads to higher throat calprotectin levels. This hypothesis will be tested in a larger study.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine Centre for Trials Research (CNTRR) |
Additional Information: | This article is Open Access: CC BY license (https:// creativecommons. org/ licenses/ by/4.0/) |
Publisher: | Royal College of General Practitioners |
ISSN: | 2398-3795 |
Date of First Compliant Deposit: | 9 January 2020 |
Date of Acceptance: | 23 July 2019 |
Last Modified: | 07 Nov 2023 19:38 |
URI: | https://orca.cardiff.ac.uk/id/eprint/128406 |
Citation Data
Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |